Meeting
2016 Genitourinary Cancers Symposium
Trough blood levels of sunitinib for Asian (Japanese) patients with metastatic renal cell carcinoma and therapeutic drug monitoring.
Authors
Yoshihide Kawasaki
Tohoku University Graduate School of Medicine, Sendai, Japan
Yoshihide Kawasaki , Shinnya Takasaki , Akihiro Ito , Koji Mitsuzuka , Shinichi Yamashita , Naoki Kawamorita , Hideaki Izumi , Hisanobu Adachi , Yasuhiro Kaiho , Masaki Tanaka , Masafumi Kikuchi , Hiroaki Yamaguchi , Nariyasu Mano , Yoichi Arai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 508)
DOI
10.1200/jco.2016.34.2_suppl.508
Abstract #
508
Poster Bd #
D13
Abstract Disclosures
Similar Posters
Poster
2012 Genitourinary Cancers Symposium
Efficacy and safety of pazopanib as a subsequent treatment after failure of other targeted agents in patients with metastatic renal cell carcinoma (mRCC).
First Author: Jiahuai Tan
Poster
2019 Genitourinary Cancers Symposium
Exploratory endpoints in a FARETES study of the efficacy of testosterone in metastatic renal cell carcinoma (mRCC) patients.
First Author: Ilya Tsimafeyeu
Poster
2022 ASCO Genitourinary Cancers Symposium
Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).
First Author: Matthew Scott Ernst
Poster
2022 ASCO Genitourinary Cancers Symposium
Real-world experience of axitinib as second-line treatment in metastatic renal cell carcinoma: Analysis of the Swedish population.
First Author: Angela Strambi